A Rat THC Binding Study Paired Partial Open-Field Tolerance With Regional Receptor-Density Changes

A 1994 rat study paired repeated-THC changes in open-field behavior with lower cannabinoid-receptor density in selected brain regions. Behavioral effects became smaller but did not all disappear, limiting an all-or-nothing account of tolerance.

The open-field measures were separate

Locomotion, exploration and time spent inactive changed differently after repeated exposure. Their attenuation should not be collapsed into complete behavioral recovery. A laboratory movement pattern also cannot independently establish a human's functional impairment.

The binding work had defined regional sampling

The researchers characterized binding in striatal, limbic-forebrain and ventral-mesencephalic preparations. The supplied abstract reported significant density decreases in the striatum and limbic forebrain. It does not establish an identical effect in every brain area or every receptor system.

The association was not a complete causal test

A molecular change accompanying tolerance can motivate an explanatory hypothesis. It does not prove that the measured density change alone produced each behavioral effect. The available abstract is truncated, so details absent from it should not be reconstructed as findings.

Interpreting the evidence

The useful conclusion is a paired behavioral and regional binding observation under one rat regimen. It does not validate receptor density as a personal tolerance measure or establish that a lower binding signal predicts absence of all THC effects.

Related reading: interpreting cannabis tolerance claims.

Research reference

Rodríguez de Fonseca F; Gorriti MA; Fernández-Ruiz JJ; Palomo T; Ramos JA (1994). Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacology, biochemistry, and behavior. doi:10.1016/0091-3057(94)90108-2.

This analysis draws on the supplied study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

A 2021 pilot study reported strong initial antinociceptive responses to THC and cannabinolic acid, followed by decreasing responses over subsequent days. The evidence concerns adult male mice and experimental mechanical and thermal tests. The study evaluated two nociceptive domains Mechanical and thermal responses were assessed after systemic intraperitoneal administration. Those…

Spread the love

Read Article: A Pilot Mouse Study Found Declining THC and CBNA Antinociception With Repeated Administration

Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A 2001 mouse study found different opioid- and cannabinoid-receptor protein patterns across midbrain and spinal cord after short-term THC–morphine treatment. A statement about total receptor change would obscure those tissue-specific comparisons. The comparison included separate treatment groups Investigators assessed THC, morphine and their combination using Western blot measurements. Opioid-receptor protein…

Spread the love

Read Article: Short-Term THC–Morphine Treatment Produced Different Receptor-Protein Patterns in Mouse Midbrain and Spinal Cord

A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

A 2003 study found that selected kinase inhibitors reversed THC antinociceptive tolerance while others did not. One higher-dose intervention reduced THC's acute antinociceptive effect, illustrating a different outcome from reversing tolerance. The panel included useful negatives The study tested interventions directed at several kinases. Some did not affect tolerance under…

Spread the love

Read Article: A THC Kinase Study Distinguished Reversing Tolerance From Reducing the Initial Drug Effect

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us